No association between serum paraoxonase, arylesterase activities, and hydatidiform mole

International Journal of Gynecological Cancer

Volumn 21, Issue 1, 2011, Pages 149-152

  Ozturk, Ebru ^a   Balat, Ozcan ^a   Dikensoy, Ebru ^a   Ugur, Mete Gurol ^a   Ozcan, Caglayan ^a   Aydin, Abdullah ^a   Erel, Ozcan ^b   Kul, Seval ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Arylesterase; Hydatidiform mole; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYDATIDIFORM MOLE; PHENOTYPE; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYDATIDIFORM MOLE; PHENOTYPE; PREGNANCY; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 79951494076     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182021c59     Document Type: Article

References (19)

1. Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol. 2009;112:654-662.
2. Canales A, Sanchez-Muniz FJ. Paraoxonase, something more than an enzyme? Med Clin. 2003;121:537-548. (Pubitemid 37429019)
3. Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 1995;96:2882-2891.
4. Guyton KZ, Kensler TW. Oxidative mechanisms in carcinogenesis. Br Med Bull. 1993;49:481-483.
5. Stevens VL, Rodriguez C, Talbot JT, et al. Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort. Prostate. 2008;68:1336-1340.
6. Korpacka KM, Boehm D, Matusiewicz M, et al. Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes - connection with inflammation. Clin Biochem. 2008;41:804-811.
7. Camuzcuoǧlu H, Arioz DT, Toy H, et al. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Gynecol Oncol. 2009;112:481-485.
8. Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet. 1983;35:1126-1138. (Pubitemid 14201166)
9. Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clim Biochem. 1992;30:391-395.
10. Eckerson HW, Romson J, Wyte C, et al. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet. 1983;35: 214-227. (Pubitemid 13111118)
11. Mackness B, Durrington PN, Mackness MI. Human serum paraoxonase. Gen Pharmacol. 1998;31:329-336. (Pubitemid 28398854)
12. Soran H, Younis NN, Charlton-Menys V, et al. Variation in paraoxonase-1 activity and atherosclerosis. Curr Opin Lipidol. 2009;20:265-274.
13. Chung FL, Nath RG, Ocando J, et al. Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources. Cancer Res. 2000;60:1507-1511. (Pubitemid 30183415)
14. Sanchez-Perez Y, Carrasco-Legleu C, Garcia-Cuellar C, et al. Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett. 2005;217:25-32. (Pubitemid 39642863)
15. Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med. 1996;335:1740-01748.
16. Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly. 2003; 133:563-566. (Pubitemid 37499328)
17. Harma M, Harma M, Kocyigit A, et al. Increased DNA damage in patients with complete hydatidiform mole. Mutat Res. 2005;583:49-54. (Pubitemid 40615202)
18. Harma M, Harma M. Defective placentation and resultant oxidative stress play a similar role in complete hydatidiform mole to that in preeclampsia and early pregnancy loss. Med Hypotheses. 2006;66:100-102. (Pubitemid 41605112)
19. Ferré N, Camps J, Fernández-Ballart J, et al. Longitudinal changes in serum paraoxonase-1 activity throughout normal pregnancy. Clin Chem Lab Med. 2006;44:880-882.